Logo
x

Search

Subscribe Now

HFrEF

Boehringer Ingelheim and Eli Lilly's Jardiance (empagliflozin) Receive the US FDA's Approval for the Treatment of Heart Failure with Reduced Ejection Fraction

Boehringer Ingelheim and Eli Lilly's Jardiance (empagliflozin) Receive the US FDA's Approval for the Treatment of Heart Failure wi...

  • August 19, 2021
Boehringer Ingelheim and Eli Lilly Report Results of Jardiance in Adults with HFrEF Regardless of Chronic Kidney Disease Status

Boehringer Ingelheim and Eli Lilly Report Results of Jardiance in Adults with HFrEF Regardless of Chronic Kidney Disease Status

  • October 26, 2020
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2024 PharmaShots - All Rights Reserved.